Hemostemix Inc (HMTXF) Stock Price & News

All values in CAD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	401.55K	2.08M	272.64K	9.32K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	879.88K	120.19K	353.65K	493.73K
Operating expense	1.76M	2.30M	645.85K	505.08K
Total operating expenses	1.76M	2.30M	645.85K	505.08K
Operating income	-1.76M	-2.30M	-645.85K	-505.08K
Other non operating income	315.78K	-789.35K	-195.81K	-100.92K
EBT including unusual items	-497.76K	-2.62M	-789.98K	-632.42K
EBT excluding unusual items	-1.48M	-3.15M	-926.72K	-654.50K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-497.76K	-2.62M	-789.98K	-632.42K
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	79.47K	-	-
Interest expense	-193.39K	-	-59.88K	-60.98K
Net interest expenses	-193.39K	79.47K	-59.88K	-60.98K
Depreciation and amortization charges	11.00	12.00	5.00	5.00
EBITDA	-1.76M	-2.30M	-645.84K	-505.08K
Gain or loss from assets sale	-	-	-	-

Finance